Search

Displaying results 8861 - 8870 of 10000 in total
  1. Drug

    Aclarubicin

    go.drugbank.com/drugs/DB11617
    Investigational

    Categories: Anthracyclines and Related Substances, Topoisomerase II Inhibitors
  2. Drug

    V-SARS

    go.drugbank.com/drugs/DB15812
    Investigational

    [COVID-19 convalescent plasma] is currently being acquired from recovered COVID-19 patients and used as prophylaxis for the virus. … This therapeutic concept was applied to the development of V-SARS, which heat inactivates the plasma, and packages it into a once-daily pill form.

  3. Drug

    N-Ethyl-5'-Carboxamido Adenosine

    go.drugbank.com/drugs/DB03719
    Experimental

    A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. [PubChem]

    Synonyms: N-Ethyl-5'-Carboxamido Adenosine
  4. Drug

    Florasulam

    go.drugbank.com/drugs/DB15316
    Experimental

    Florasulam is under investigation in clinical trial NCT01193465 (Temperature and Humidity Among Different Anesthesia Work-station).

  5. Drug

    Bedoradrine

    go.drugbank.com/drugs/DB05590
    Investigational

  6. Drug

    Reparixin

    go.drugbank.com/drugs/DB12614
    Investigational

    1, and Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus. … Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type

  7. Drug

    Ropanicant

    go.drugbank.com/drugs/DB19134
    Investigational

    Ropanicant is under investigation in clinical trial NCT06126497 (Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients).

  8. Drug

    Mavoglurant

    go.drugbank.com/drugs/DB13004
    Investigational

    Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).

  9. Drug

    CRA-028129

    go.drugbank.com/drugs/DB05951
    Experimental

    CRA-028129 is cathepsin S inhibitor which is under investigation for the treatment of psoriasis.

  10. Drug

    Pegapamodutide

    go.drugbank.com/drugs/DB14817
    Investigational

    Pegapamodutide is under investigation in clinical trial NCT02188303 (A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants).